We caution you that forward-looking statements are not guarantees of future performance and that our actual results may differ materially from those made in or suggested by the forward-looking statements contained in this communication.
Gery, S., Komatsu, N., Baldjyan, L., Yu, A., Koo, D., & Koeffler, H
Life changing experience!Posted onJohn JonesboroSeptember 10, 2025Trustindex verifies that the original source of the review is Google.I've been with TRT MD since 2021
0.1% (placebo) Steady State: Achieved after 4-5 weeks of weekly dosing Safety: Nausea (68% at 4.5 mg), vomiting (32%), generally mild-moderate and transient Discontinuation: 14% discontinued due to GI adverse events Appetite Effects: Significant reductions in Visual Analogue Scale (VAS) hunger scores Publication: Lau DCW, et al
Zeng, G.C